Therapeutic Angiogenesis: Potential Role of Basic Fibroblast Growth Factor in Patients with Severe Ischaemic Heart Disease

Author： Simons M.   Laham R.J.   Post M.   Sellke F.W.  

Publisher： Adis International

ISSN： 1173-8804

Source： BioDrugs, Vol.14, Iss.1, 2000-07, pp. : 13-20

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Role of the Complement System in Ischaemic Heart Disease: Potential for Pharmacological Intervention

By Shernan S.K.  

BioDrugs, Vol. 15, Iss. 9, 2001-09 ,pp. : 595-607

Adis International

Access to resources Recommend Favorite

Fibroblast Growth Factor-21 as a Therapeutic Agent for Metabolic Diseases

By Kharitonenkov Alexei   Shanafelt Armen B.  

BioDrugs, Vol. 22, Iss. 1, 2008-01 ,pp. : 37-44

Adis International

Access to resources Recommend Favorite

Targeting Nerve Growth Factor in Pain: What is the Therapeutic Potential?

By Watson Judy J.   Allen Shelley J.   Dawbarn David  

BioDrugs, Vol. 22, Iss. 6, 2008-01 ,pp. : 349-359

Adis International

Access to resources Recommend Favorite

Therapeutic Potential of Hepatocyte Growth Factor for Treating Neurological Diseases

By  

Current Drug Therapy, Vol. 6, Iss. 3, 2011-08 ,pp. : 197-206

Bentham Science Publishers

Access to resources Recommend Favorite

Contribution of nursing to risk factor management as perceived by patients with established coronary heart disease

By Scholte op Reimer W.J.M.   Jansen C.H.   de Swart E.A.M.   Boersma E.   Simoons M.L.   Deckers J.W.  

European Journal of Cardiovascular Nursing, Vol. 1, Iss. 2, 2002-06 ,pp. : 87-94

Elsevier

Access to resources Recommend Favorite